The decision to shut down sales of Watson for Drug Discovery marks another setback in the company’s effort to apply AI to various areas of health care. | Continue reading
A small Indian journal, IJME, has an impressive list of staff and contributors and has been earning plaudits from the science community lately. | Continue reading
These machine-learning systems present a particularly thorny problem for the FDA, because it's essentially trying to hit a moving target in regulating them. | Continue reading
Biogen and its partner, Eisai, said an analysis concluded that aducanumab was unlikely to benefit Alzheimer’s patients compared to placebo. | Continue reading
An underreported story about a half-baked advance caught fire and scorched its way through social media, onto TV, and into the minds of millions. | Continue reading
Robert McIntyre and Nectome are determined to claw their way out of scientific purgatory and show they can preserve brains and perhaps memories. | Continue reading
The WHO predicts there are adequate supplies of an experimental Ebola vaccine to control the outbreak in the Democratic Republic of the Congo. | Continue reading
Want to know why an industry that views itself as lifesaving and heroic is viewed by much of the public as price gouging and venal? Look here. | Continue reading
In something like a microscopic prison break, blood cells slip unseen from the enclosed depths of the bone marrow into the general circulation. | Continue reading
The research could allow scientists to create more precise maps of the brain and find clues to the causes of brain diseases. | Continue reading
The research could allow scientists to create more precise maps of the brain and find clues to the causes of brain diseases. | Continue reading
Cold Spring Harbor Laboratory has stripped the Nobel laureate of his last remaining honorary positions. | Continue reading
Cold Spring Harbor Laboratory has stripped the Nobel laureate of his last remaining honorary positions. | Continue reading
The pharmaceutical giant will purchase Loxo Oncology, a tiny startup, for $8 billion in cash to gain access to the company’s cancer medicines. | Continue reading
A university professor has some theories, and now has in his possession human tissue handed down through the generations to try to test them. | Continue reading
“It’s not just random here or there,” said M. Roy Wilson, co-chair of the advisory committee to the NIH director that wrote the report. “It is significant.” | Continue reading
The number of times a scientific paper is cited is a poor proxy of quality, and can lead to fake news. We need a better way to evaluate research quality. | Continue reading
Shanghai's Pharma Valley lags Kendall Square in capital, entrepreneurial talent, and scientific firepower, but its biotech ecosystem is growing rapidly. | Continue reading
A researcher's claim that he used genome editing to alter DNA of human embryos, resulting in the birth a few weeks ago of twin girls, stunned scientists. | Continue reading
The Teva pricing appears to undercut a notion promoted by FDA officials that approving more generics can help relieve pocketbook pressure on Americans. | Continue reading
The medicine has “unique features” that make it well-suited for the military, a point that factored heavily into the approval. | Continue reading
An inadvertant typographical glitch, generated by a computer, sank a VA physician's funding request for a project seeking to help vets with PTSD. | Continue reading
An inadvertant typographical glitch, generated by a computer, sank a VA physician's funding request for a project seeking to help vets with PTSD. | Continue reading
Public health experts say they see reason to be optimistic but warned against drawing firm conclusions based on a half-year’s worth of data. | Continue reading
Harvard Medical School and Brigham and Women’s Hospital have recommended that 31 papers from a former lab director be retracted from medical journals. | Continue reading
One of the medical world’s most respected expert bodies is in turmoil as its annual meeting gets underway after its governing board voted to expel a member. | Continue reading
In response to criticism that it soft-pedaled the cancer risk from alcohol, the NIH alcoholism institute changed the wording on its website. | Continue reading
Burkina Faso granted scientists permission to release genetically engineered mosquitoes as soon as this month — a key step in efforts to eliminate malaria. | Continue reading
When the new app can get a reading, it can accurately detect atrial fibrillation 99 percent of the time, according to data Apple submitted to FDA. | Continue reading
Few pieces of medical advice have been so consistent for so long, and so ignored, as the admonition not to use foreign objects to remove earwax. | Continue reading
The patent, issued earlier this year, concerns a new formulation of buprenorphine, one of the medications shown to help people with opioid addiction. | Continue reading
The company is betting a smartphone app can help close the gap between patients seeking experimental treatments and cancer centers ready to offer it. | Continue reading
The trial, co-sponsored by Vertex Pharmaceuticals, will test the genome-editing technique in patients with the blood disorder beta thalassemia. | Continue reading
A record percentage of startups pitched ideas for the life sciences, like a blood test that uses women’s used menstrual pads instead of needles. | Continue reading
A Google DeepMind AI system can identify dozens of eye diseases and point out the portions of scans it relies upon to make diagnoses. | Continue reading
Dr. Toby Cosgrove, the longtime president and CEO of Cleveland Clinic, is the latest health care bigwig to pick Google as a landing pad. | Continue reading
Vyera Pharmaceuticals, once known as Turing Pharmaceuticals, is losing money and watching sales slip. It's also considering another name change. | Continue reading
Eric Betzig's newest microscope looks nothing like the one you remember from school. It can see into a living, breathing cell. | Continue reading
A new study suggests CRISPR can cause significantly greater genetic havoc than experts thought; leading CRISPR companies scrambled to play down the threat. | Continue reading
STAT interviewed a handful of researchers on how they came up with some of the more memorable gene names. Here’s what they had to say in their own words. | Continue reading
The drug maker reported positive secondary results from a mid-stage study in hopes of saving a drug many in the field had written off entirely. | Continue reading
The NIH's All of Us Research Program, which aims to collect sensitive health and genetic information from one million Americans, has put in place layers of security and privacy protections. | Continue reading
Epidiolex, a drug manufactured by GW Pharmaceuticals, is made of a cannabidiol, or CBD, a component of marijuana, and is prescribed as an oil. | Continue reading
Beyond the impossibility of obtaining parental consent for such testing, it would be challenging to obtain informed consent from kids. | Continue reading
The new right-to-try law allows drug makers to earn a profit by selling unproven therapies to desperate patients. The FDA can't do anything about it. | Continue reading
Atul Gawande, the surgeon and author, has been selected to lead the health-care venture from Amazon, J.P. Morgan, and Berkshire Hathaway. | Continue reading
An alarming number of oncologists have trouble quickly performing and interpreting genetic tests. It's a problem the cancer community needs to fix. | Continue reading
An experimental treatment for Duchenne muscular dystrophy produced jaw-dropping increases in a crucial muscle protein normally missing in patients. | Continue reading